Hemostasis Analyzers Market - Top Leaders and Business Intelligence


Posted November 12, 2020 by RosyW_2020

Hemostasis Analyzers Market by Product (Clinical Laboratory, consumables, reagents, PoCT, Manual, Automated), Test (PT,Fibrinogen,APTT, ACT, D Dimer), Technology (Optical, Mechanical) End User (Clinical Labs, Hospitals).
 
Coagulation analyzers and consumables are used to evaluate the coagulation profiles of blood samples, which are utilized for clotting-based or chromogenic assays and for diagnosing clotting factor deficiencies. They are primarily used in wound, injury, and pre- and post-operative management.

According to market research report the global Hemostasis Analyzers Market is projected to reach USD 5.0 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 5.7% between 2020 and 2025.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197226392

Siemens Healthineers focuses on the introduction of innovative products to gain a competitive advantage in the market. For instance, in August 2016, Siemens launched the Sysmex CS-2500 System, a new mid-volume coagulation analyzer. The company also pursues the inorganic growth strategy of agreements in order to increase its share in the market. In April 2016, Siemens and Sysmex (Japan) extended their long-standing global agreement on hemostasis testing. This agreement allows laboratory customers around the world to continue to benefit from the largest portfolio of hemostasis systems and reagents.

Thermo Fisher held the second position in the global Hemostasis Analyzers Market. The company is a leading provider of life science diagnostic tools. Thermo Fisher has a significant global footprint owing to its strong sales and distribution network. The strong position of the company in the coagulation analyzers market can be attributed to its strong brand value. The company also has a strong distribution network for sales and services, making it a prominent player in the Hemostasis Analyzers Market.

Roche Diagnostics held the third position in the global Hemostasis Analyzers Market. The company focuses on introducing innovative and technologically advanced products in the market. For instance, in June 2017, Roche launched the cobas t 711 coagulation analyzer. The company has a strong portfolio of coagulation analyzers, as well as reagents and assays.

Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=197226392

North America (comprising the US and Canada) accounted for the largest share of the global Hemostasis Analyzers Market in 2019, followed by Europe. Factors such as the increasing prevalence of lifestyle diseases and the rising incidence of blood disorders are stimulating the growth of the coagulation analyzers market in North America.


Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
[email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By MarketsandMarkets™ INC.
Phone 1-888-600-6441
Business Address 630 Dundee Road Suite 430
Northbrook, IL 60062
Country United States
Categories Business , Health , Medical
Tags hemostasis analyzers market
Last Updated November 12, 2020